| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |